Akadeum’s cell therapy products are designed to address the need for scalability, time, and improved allogeneic and autologous workflows, resulting in better cell health, purity, recovery, and viability. Akadeum has developed the first at-scale negative selection kit (Human T Cell Leukopak Isolation Kit), enabling untouched cells and a workflow desired by researchers for years.
GMP-grade and Clinical-Ready products are available, enabling smooth transitions from research through commercialization of cell therapeutics.